Said Hajouli
Internal Medicine · Charleston, WVNPI 1073995577
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.2%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Abbott at 34.1% of the total. 2025 is the largest year on record at $4,506, 6.0 times the $749 reported in 2022. Among internal medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $94.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$533
- Heartflow, Inc.$396
- AstraZeneca$381
- Abiomed$264
- plus $831 from 13 others
What the payments were for
- Grants$2,06730%
- Travel & lodging$1,41421%
- Food & beverage$2,79841%
- Education$5067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $2,312 |
| Medtronic | 2 | $2,067 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $533 |
| Heartflow, Inc. | 3 | $396 |
| AstraZeneca | 12 | $381 |
| Abiomed | 7 | $264 |
| Shockwave Medical, Inc | 3 | $160 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $107 |
| Boehringer Ingelheim | 1 | $98 |
| Amgen | 1 | $62 |
| Edwards Lifesciences | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $49 |
| Kestra Medical Technology Services, Inc. | 2 | $43 |
| Recor Medical Inc | 1 | $42 |
| Stryker | 1 | $32 |
| Boston Scientific | 1 | $24 |
| Novartis | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,784 in reported general payments places this provider in the 90th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 20 | $24,573 |
| Metoprolol Succinate | 49 | $1,111 |
| Ranolazine ErRanolazine | 11 | $831 |
| Atorvastatin Calcium | 65 | $627 |
| ClopidogrelClopidogrel Bisulfate | 59 | $617 |
| Ezetimibe | 17 | $532 |
| Rosuvastatin Calcium | 31 | $445 |
| Carvedilol | 11 | $118 |
| Spironolactone | 14 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $381 | $24,57320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 573 internal medicine providers in West Virginia.
Other internal medicine in Charleston
- William ChapmanCharleston$1.7M
- Phillip TriplettCharleston$17K
- Roy BowdenCharleston$14K
- Richard CapitoCharleston$11K
- Ghali Ibrahim-BachaCharleston$9K
- Jack KinderCharleston$8K
- Bradley HenryCharleston$8K
- Brijal PatelCharleston$8K
- William JeffreyCharleston$7K
- Justin BaileyCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.